Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 8, 2002, Pages 443-448

  Amirghofran, Z ^a   Sheikhi, A ^a   Kumar, P ^a   Saberi Firouzi, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Malignancy; Peritoneal and pleural effusions; SHLA I

Indexed keywords

HLA ANTIGEN CLASS 1;

ADULT; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERITONEAL FLUID; PERITONEUM; PLEURA EFFUSION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUMOR IMMUNITY;

ASCITIC FLUID; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; PLEURAL EFFUSION, MALIGNANT;

EID: 0036039694     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0371-0     Document Type: Article

References (37)

1. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas
2. Soluble HLA in human body fluids
3. Immunomodulation by soluble HLA class I
4. Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions
5. Soluble HL-A7 antigen: Localization in the beta-lipoprotein fraction of human serum
6. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients
7. High concentration of soluble HLA-DR in the synovial fluid: Generation and significance in "rheumatoid-like" inflammatory joint diseases
8. Soluble HLA class I in epithelial lining fluid of lung transplants: Associations with graft outcome
9. Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro
10. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients
11. Antigen- presenting function of human peritoneum mesothelial cells isolated from a pancreatic carcinoma patient after mutant Ras peptide vaccination
12. Natural killer cells in human solid tumors
13. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: Correlation with anti-DNA antibodies and leukopenia
14. Influence of preoperative sHLA I concentrations on the histological development of the liver graft
15. MHC class I molecules, structure, and function
16. Increased soluble serum HLA class I antigens in patients with lymphoma
17. The characterization of peritoneal and pleural exudate cells from malignant effusions
18. Soluble HLA class I and class II antigens in patients with multiple sclerosis
19. Lymphokine-activated killer cell suppressor factor in malignant effusions
20. Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia
21. Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts
22. Quantification of serum-soluble HLA class I antigens in patients with gastric cancer
23. Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer
24. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions
25. Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis
26. Natural killer cell activity in patients with hepatocellular carcinoma: A new prognostic indicator after hepatectomy
27. Soluble class HLA antigens in serum of patients with brain tumors
28. Soluble HLA class I antigens in serum of healthy individuals-population study
29. Interaction between the human NK receptors and their ligands
30. Detection of soluble class I molecules (non-HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture
31. Pathways of antigen processing and presentation
32. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum
33. Soluble HLA class I antigens in plasma of patients with malignant melanoma
34. Molecular forms of soluble HLA in body fluids: Potential determinants of bodyodor cues
35. Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA
36. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients
37. Soluble MHC class I molecules in human body fluids